AI Verdict
RUN has stronger fundamentals based on our AI analysis.
RVMDW vs RUN Fundamental Comparison
| Metric | RVMDW | RUN |
|---|---|---|
| Revenue | $0.0 | $3.0B |
| Net Income | $-1.1B | $449.9M |
| Net Margin | N/A | 15.2% |
| ROE | -69.3% | 14.4% |
| ROA | -48.0% | 2.0% |
| Current Ratio | 7.14x | 1.66x |
| Debt/Equity | 0.00x | 4.69x |
| EPS | $-5.95 | $1.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RVMDW vs RUN: Frequently Asked Questions
Is RVMDW or RUN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RUN has stronger fundamentals. RVMDW is rated STRONG SELL (88% confidence) while RUN is rated HOLD (65% confidence). This is not investment advice.
How does RVMDW compare to RUN fundamentally?
Revolution Medicines, Inc. has ROE of -69.3% vs Sunrun Inc.'s 14.4%. Net margins are N/A vs 15.2% respectively.
Which stock pays higher dividends, RVMDW or RUN?
RVMDW has a dividend yield of N/A or no dividend while RUN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RVMDW or RUN for long term?
For long-term investing, consider that RVMDW has STRONG SELL rating with 88% confidence, while RUN has HOLD rating with 65% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RVMDW vs RUN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVMDW vs RUN, the AI consensus favors RUN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.